Your browser doesn't support javascript.
loading
Protection of colorectal anastomosis with an intraluminal bypass device for patients undergoing an elective anterior resection: a pilot study.
Reshef, A; Ben-Arie, G; Pinsk, I.
Afiliación
  • Reshef A; Colorectal Unit, Department of Surgery, Soroka University Medical Center, Beersheba, Israel. areshef1@yahoo.com.
  • Ben-Arie G; Diagnostic Imaging Department, Soroka University Medical Center, Beersheba, Israel.
  • Pinsk I; Colorectal Unit, Department of Surgery, Soroka University Medical Center, Beersheba, Israel.
Tech Coloproctol ; 23(6): 565-571, 2019 Jun.
Article en En | MEDLINE | ID: mdl-31278459
ABSTRACT

BACKGROUND:

Currently, the only clinically valid method to prevent morbidity and mortality related to colorectal anastomotic leaks is by construction of a protective ileostomy. Intraluminal bypass might also be a possible way to proctect the anastomosis. The aim of the present study was to evaluate the CG-100 intraluminal bypass device for the reduction of anastomosis-related morbidity and stoma creation in cases of rectal resection.

METHODS:

A prospective study was conducted on patients having sphincter-preserving rectal resection who were treated with the CG-100 device at Soroka University Medical Center, Beer Sheva, Israel between May 2015 and February 2017. The device was implanted during surgery and removed after 10 ± 1 days. All patients underwent a radiologic leak test with water-soluble contrast prior to removal of the device. Patients were followed for 30 days. Information about adverse events, anastomotic leaks, device usability and tolerance were collected.

RESULTS:

Forty-seven patients participated in the study. Most patients were operated on due to cancer 44 (93.6%). Four (9%) patients received a primary protective stoma on top of the CG-100 device as part of the learning curve of the surgical team and none required a stoma after device removal. Five (9%) serious adverse events were reported, but only 2 (4%) were classified as related to the device. One was a transient enterocutaneous fistula after removal of the device. The second was an asymptomatic radiologic leak in 1 (2.1%) patient which was treated by keeping the device in place and antibiotic treatment for another 10 days without creation of diverting ileostomy.

CONCLUSIONS:

CG-100 may provide a safe method for fecal diversion over a newly created anastomosis without the complications related to stoma creation and closure. A larger prospective randomized study in patients originally scheduled to receive diverting stoma is needed to confirm these findings.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Complicaciones Posoperatorias / Ileostomía / Estomas Quirúrgicos / Fuga Anastomótica / Proctectomía Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Tech Coloproctol Asunto de la revista: GASTROENTEROLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Israel

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Complicaciones Posoperatorias / Ileostomía / Estomas Quirúrgicos / Fuga Anastomótica / Proctectomía Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Tech Coloproctol Asunto de la revista: GASTROENTEROLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Israel